Abstract
Interleukin-34 (IL-34) is a newly discovered cytokine as an additional ligand for colony stimulating factor-1 receptor (CSF1R), and its functions are expected to overlap with colony stimulating factor-1/macrophage-colony stimulating factor. We have previously shown that the IL-34 is primarily produced by neurons in the central nervous system (CNS) and induces proliferation and neuroprotective properties of microglia which express CSF1R. However, the functions of IL-34 in the CNS are still elucidative. Here we show that CNS capillary endothelial cells also express CSF1R. IL-34 protected blood-brain barrier integrity by restored expression levels of tight junction proteins, which were downregulated by pro-inflammatory cytokines. The novel function of IL-34 on the blood-brain barrier may give us a clue for new therapeutic strategies in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Blood-Brain Barrier / immunology*
-
Blood-Brain Barrier / metabolism
-
Capillary Permeability
-
Cells, Cultured
-
Cytokines / immunology
-
Endothelial Cells / immunology*
-
Endothelial Cells / metabolism
-
Interleukins / immunology*
-
Mice
-
Mice, Inbred C57BL
-
Tight Junction Proteins / genetics
-
Tight Junction Proteins / immunology
-
Up-Regulation
Substances
-
Cytokines
-
Interleukins
-
Tight Junction Proteins
-
interleukin-34, mouse
Grants and funding
This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.